Amneal Pharmaceuticals, Inc. (AMRX) › Net IncomeAmneal Pharmaceuticals, Inc. (AMRX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2016: $02017: $02018: -$19.74M2019: -$603.57M2020: $67.79M2021: $13.16M2022: -$270.58M2023: -$83.99M2024: -$116.89M2025: $72.06M$72.06M2016Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$72.06M+161.6%2024-$116.89M-39.2%2023-$83.99M+69.0%2022-$270.58M-2155.6%2021$13.16M-80.6%2020$67.79M+111.2%2019-$603.57M-2957.0%2018-$19.74M—2017$0—2016$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share